Exploring the Potential Use of a PBMC-Based Functional Assay to Identify Predictive Biomarkers for Anti-PD-1 Immunotherapy

The absence of reliable, robust, and non-invasive biomarkers for anti- Programmed cell death protein 1 (PD-1) immunotherapy is an urgent unmet medical need for the treatment of cancer patients. No predictive biomarkers have been established based on the direct assessment of T cell functions, the pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacot, Silvia M., Harper, Taylor A., Matthews, Rebecca L., Fennell, Christie Jane, Akue, Adovi, KuKuruga, Mark A., Lee, Shiowjen, Wang, Tao, Feldman, Gerald M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730837/
https://www.ncbi.nlm.nih.gov/pubmed/33261003
http://dx.doi.org/10.3390/ijms21239023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730837/
https://www.ncbi.nlm.nih.gov/pubmed/33261003
http://dx.doi.org/10.3390/ijms21239023

Ejemplares similares